Angel Insights Webinar Series
Upcoming Angel Capital Association webinar featuring Ziad Moukheiber, CEO of Boston Harbor Angels. Pre-Money Valuations: Do They Matter as Much as Many Angels Think? Read more >>
05
Oct
04
Oct
September VC Funding Update: 54 Startups Raise More Than a Billion Dollars
The summer slump wore off in September with over 50 Boston startups raising north of a billion dollars in venture funding, including Platelet BioGenesis. Read more >>
04
Oct
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced the presentation of three abstracts at the American College of Rheumatology (“ACR”) 2019 Annual Meeting being held November 8-13, 2019 in Atlanta, Georgia. Read more >>
03
Oct
MarTech Interview with Lynn Browne and Mollie Kehoe, Co-Founders at BrandVerge
How did you get into technology? What inspired you to start BrandVerge? Lynn: I think what really inspired us to do both, is personal frustration in our professional careers. Mollie: When we sat down and really thought about it, there’s so many technologies that have disrupted and helped make our personal lives easier. Read more >>
03
Oct
One of Louisville’s largest manufacturing firms acquires Arizona company
This deal comes after Rev-A-Shelf acquired CompoKeeper, a brand of kitchen composters, from 1908 Brands of Boulder, Colo in 2018. Read more >>
03
Oct
New technology may aid emergency preparedness
The Department of Health and Human Services (HHS) has earmarked funds to aid the development of new technology that could bolster emergency preparedness by producing platelets outside the human body. If the two-year, $4.9 million agreement between HHS Biomedical Advanced Research and Development Authority (BARDA) and Platelet BioGenesis, Inc. (PBG) of Cambridge, Mass., produces the desired results, the technology would improve emergency preparedness by making additional blood products available to save lives during a radiological or nuclear emergency. Read […]
03
Oct
Emovi Announces Results of Clinical Trial to Manage Knee Osteoarthritis with KneeKGTM
Today, Emovi, Inc. announces positive results from a randomized, controlled trial involving KneeKG™, Emovi’s flagship medical device and the first device that enables healthcare professionals to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. Read more >>
02
Oct
Corbion, KnipBio score wins for their alternative aquafeeds
Corbion and KnipBio each secured positive developments recently in the advancement of the development and marketing of their alternative aquafeed ingredients. Read more >>
02
Oct
Wasabi scores ‘most important deal’ yet with Japanese telecom giant
Boston-based Wasabi Technologies, Inc. has scored a partnership and an investment that will pave the cloud storage provider’s way to the Japanese market in a deal that serial entrepreneur and CEO David Friend called “the most important business deal we’ve done since starting the company.” Read more >>
01
Oct
Platelet BioGenesis Receives $56 Million Contract from BARDA
Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure. Read more >>